ArticleESMO open2026

Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database.

G Farinea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.